Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FJ4KC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,763
Award facts
- Contract value 100% obligated
- $28,762.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,762.84 to AmerisourceBergen Drug Corp for the supply of XGEVA 120 mg/1.7 mL vials. This firm fixed-price contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. XGEVA (denosumab) is a specialty pharmaceutical used primarily in oncology and bone health treatment, consistent with the company's portfolio of brand-name medications and specialized medical supplies. This delivery order exemplifies the routine pharmaceutical replenishment activities conducted through the company's prime vendor relationship with DLA, which enables flexible sourcing of diverse pharmaceutical products and medical commodities to support Defense Health Agency and other federal healthcare customers globally.
Quick answers
Who was awarded contract SPE2DB25FJ4KC?
SPE2DB25FJ4KC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FJ4KC worth?
The government has obligated $28,763 on SPE2DB25FJ4KC.
Is contract SPE2DB25FJ4KC an order under another contract?
Yes. SPE2DB25FJ4KC is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ4KC competed?
The extent of competition for SPE2DB25FJ4KC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award